These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9151888)

  • 1. Transformation by bovine papillomavirus type 1 E6 is independent of transcriptional activation by E6.
    Ned R; Allen S; Vande Pol S
    J Virol; 1997 Jun; 71(6):4866-70. PubMed ID: 9151888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a second transforming function in bovine papillomavirus type 1 E6 and the role of E6 interactions with paxillin, E6BP, and E6AP.
    Das K; Bohl J; Vande Pol SB
    J Virol; 2000 Jan; 74(2):812-6. PubMed ID: 10623743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive binding to a charged leucine motif represses transformation by a papillomavirus E6 oncoprotein.
    Bohl J; Das K; Dasgupta B; Vande Pol SB
    Virology; 2000 May; 271(1):163-70. PubMed ID: 10814581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif.
    Vande Pol SB; Brown MC; Turner CE
    Oncogene; 1998 Jan; 16(1):43-52. PubMed ID: 9467941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6.
    Chen JJ; Hong Y; Androphy EJ
    Virology; 1997 Sep; 236(1):30-6. PubMed ID: 9299614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation by bovine papillomavirus type 1 E6 requires paxillin.
    Wade R; Brimer N; Vande Pol S
    J Virol; 2008 Jun; 82(12):5962-6. PubMed ID: 18385245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53.
    Cooper B; Schneider S; Bohl J; Jiang Yh; Beaudet A; Vande Pol S
    Virology; 2003 Feb; 306(1):87-99. PubMed ID: 12620801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53.
    Zimmermann H; Koh CH; Degenkolbe R; O'Connor MJ; Müller A; Steger G; Chen JJ; Lui Y; Androphy E; Bernard HU
    J Gen Virol; 2000 Nov; 81(Pt 11):2617-2623. PubMed ID: 11038372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bovine papillomavirus type 1 E6-induced sensitization to apoptosis is distinct from its transforming activity.
    Liu Z; Liu Y; Hong Y; Rapp L; Androphy EJ; Chen JJ
    Virology; 2002 Apr; 295(2):230-7. PubMed ID: 12033781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.
    Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR
    Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of exogenous p53 and E6 oncoproteins in in vitro transformation by bovine papillomavirus type 4 (BPV-4): significance of the absence of an E6 ORF in the BPV-4 genome.
    Scobie L; Jackson ME; Campo MS
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():3001-8. PubMed ID: 9367387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.
    Pim D; Storey A; Thomas M; Massimi P; Banks L
    Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of E6/E7 expression in cottontail rabbit papillomavirus latency following UV activation.
    Zhang P; Nouri M; Brandsma JL; Iftner T; Steinberg BM
    Virology; 1999 Oct; 263(2):388-94. PubMed ID: 10544111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.
    Chen JJ; Reid CE; Band V; Androphy EJ
    Science; 1995 Jul; 269(5223):529-31. PubMed ID: 7624774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP.
    Be X; Hong Y; Wei J; Androphy EJ; Chen JJ; Baleja JD
    Biochemistry; 2001 Feb; 40(5):1293-9. PubMed ID: 11170455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential.
    Elbel M; Carl S; Spaderna S; Iftner T
    Virology; 1997 Dec; 239(1):132-49. PubMed ID: 9426453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic effects of human papillomavirus type 16 E6 oncogene expression in human epithelial cell lines.
    Mythily DV; Krishna S; Tergaonkar V
    J Gen Virol; 1999 Jul; 80 ( Pt 7)():1707-1713. PubMed ID: 10423139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein.
    Beerheide W; Bernard HU; Tan YJ; Ganesan A; Rice WG; Ting AE
    J Natl Cancer Inst; 1999 Jul; 91(14):1211-20. PubMed ID: 10413422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.